Back to Search Start Over

Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease.

Authors :
Vitali P
Pan MI
Palesi F
Germani G
Faggioli A
Anzalone N
Francaviglia P
Minafra B
Zangaglia R
Pacchetti C
Gandini Wheeler-Kingshott CAM
Source :
Radiology [Radiology] 2020 Aug; Vol. 296 (2), pp. 401-410. Date of Electronic Publication: 2020 Jun 16.
Publication Year :
2020

Abstract

Background Magnetization transfer-prepared T1-weighted MRI can depict a hyperintense subregion of the substantia nigra involved in the degeneration process of Parkinson disease. Purpose To evaluate quantitative measurement of substantia nigra volume by using MRI to support clinical diagnosis and staging of Parkinson disease. Materials and Methods In this prospective study, a high-spatial-resolution magnetization transfer-prepared T1-weighted volumetric sequence was performed with a 3-T MRI machine between January 2014 and October 2015 for participants with de novo Parkinson disease, advanced Parkinson disease, and healthy control participants. A reproducible semiautomatic quantification analysis method that entailed mesencephalic intensity as an internal reference was used for hyperintense substantia nigra volumetry normalized to intracranial volume. A general linear model with age and sex as covariates was used to compare the three groups. Results Eighty participants were evaluated: 20 healthy control participants (mean age ± standard deviation, 56 years ± 11; 11 women), 29 participants with de novo Parkinson disease (64 years ± 10; 19 men), and 31 participants with advanced Parkinson disease (60 years ± 9; 16 women). Volumetric measurement of hyperintense substantia nigra from magnetization transfer-prepared T1-weighted MRI helped differentiate healthy control participants from participants with advanced Parkinson disease (mean difference for ipsilateral side, 64 mm <superscript>3</superscript> ± 14, P < .001; mean difference for contralateral side, 109 mm <superscript>3</superscript> ± 14, P < .001) and helped distinguish healthy control participants from participants with de novo Parkinson disease (mean difference for ipsilateral side, 45 mm <superscript>3</superscript> ± 15, P < .01; mean difference for contralateral side, 66 mm <superscript>3</superscript> ± 15, P < .001) and participants with de novo Parkinson disease from those with advanced Parkinson disease (mean difference for ipsilateral side, 20 mm <superscript>3</superscript> ± 13, P = .40; mean difference for contralateral side, 43 mm <superscript>3</superscript> ± 13, P = .004). Conclusion Magnetization transfer-prepared T1-weighted MRI volumetry of the substantia nigra helped differentiate the stages of Parkinson disease. ©â€‰RSNA, 2020 Online supplemental material is available for this article.

Details

Language :
English
ISSN :
1527-1315
Volume :
296
Issue :
2
Database :
MEDLINE
Journal :
Radiology
Publication Type :
Academic Journal
Accession number :
32544035
Full Text :
https://doi.org/10.1148/radiol.2020191235